LYZ and neoplasm: DC101 significantly inhibited the CPA-stimulated tumor recruitment of macrophages (CD68 marker), dendritic cells (CD74 marker), and NK cells (NKp46 marker) and their cytotoxic effectors, perforin, granzymes, and lysozymes (Figure 2C; Additional file 2).